Phenazepam and UCT CSDAU206

In recent months Phenazepam, a drug originally precribed for the Russian market, has become very popular for off-label uses in the United Kingdom, United States and Australia. Phenazepam is prescribed for the reduction of anxiety but has now been found in blood and urine samples of drivers stopped by enforcement agencies in traffic cases in these countries. In the most recent issue of LC-GC magazine (December 2011), a validated method for the analysis of Phenazepam in whole blood has been published. UCT scientist Dr. Jeff Hackett, working with analysts at the Massachussets State Police Crime Laboratory have developed a sensitive and higly efficient method for this analysis using UCT's flagship sorbent Clean Screen (CSDAU206). In this procedure whole blood samples were extracted and analyzed down to concentrations less than 1 ng per mL of whole blood. The samples were analyzed by liquid chromatography-mass spectrometry where the clean extracts were shown to have minimal matrix effects (less than 6% overall). The recoveries of the drug from whole blood using CSDAU206 SPE columns were found to be greater than 90%. These excellent analytical characteristics demonstrate why UCT is the premier manufacturer in SPE and our Clean Screen SPE columns are the best sorbents for the extraction of drugs in biological fluids.